What is Moderna's EPS (diluted)?

Moderna (MRNA) reported EPS (diluted) of -$3.40 in Q1 2026.

How has Moderna's EPS (diluted) changed year-over-year?

Moderna's EPS (diluted) decreased by 34.9% year-over-year, from -$2.52 to -$3.40.

What is the long-term trend for Moderna's EPS (diluted)?

Over 4 years (2021 to 2025), Moderna's EPS (diluted) has grown at a -28.8% compound annual growth rate (CAGR), from $28.29 to -$7.27.

What does EPS (diluted) mean?

Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Moderna MRNA EPS (Diluted)

EPS (Diluted) at other companies

PfizerPFE

$0.47-9.6%

NovavaxNVAX

-$0.06-102%

ALN

Alnylam PharmaceuticalsALNY

$1.51+1,179%

Ultragenyx PharmaceuticalRARE

-$1.84-17.2%

Vaxcyte, Inc.PCVX

-$2.30-121%

Viridian Therapeutics, Inc.VRDN

-$1.15-5.5%

Other financials

Income statement

See full

Revenue$389.0M+260%

Gross profit-$566.0M-3,244%

Operating income-$1.4B-32.2%

Net income-$1.3B-38.3%

Balance sheet

See full

Cash & equivalents$1.9B+17.4%

Total debt$1.3B+71.9%

Total equity$7.4B-26.4%

Total assets$11.5B-9.6%

Cash flow

See full

Operating cash flow-$630.0M+39.2%

CapEx$62.0M-47.0%

Free cash flow-$692.0M+40.0%

Valuation

See full

Market cap$27.09B+115%

Enterprise value$26.51B+120%

P/S12.2×+8.1×

Profitability

See full

Gross margin22.1%-32.0pp

Operating margin-153.3%+67.8pp

Net margin-143.6%+80.2pp

FCF margin-132.4%—

Returns & leverage

See full

Return on equity-36.6%+11.9pp

Debt / equity0.2×+0.1×

Current ratio2.4×-1.8×

Where this comes from

Reported directly by Moderna in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Moderna’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Moderna's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Moderna's EPS (diluted)?: Moderna (MRNA) reported EPS (diluted) of -$3.40 in Q1 2026.
How has Moderna's EPS (diluted) changed year-over-year?: Moderna's EPS (diluted) decreased by 34.9% year-over-year, from -$2.52 to -$3.40.
What is the long-term trend for Moderna's EPS (diluted)?: Over 4 years (2021 to 2025), Moderna's EPS (diluted) has grown at a -28.8% compound annual growth rate (CAGR), from $28.29 to -$7.27.
What does EPS (diluted) mean?: Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.